{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:58:09Z","timestamp":1792814289441,"version":"4.5.0"},"reference-count":141,"publisher":"Radcliffe Medical Media Ltd","issue":"3","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arrhythm Electrophysiol Rev"],"published-print":{"date-parts":[[2019,8,9]]},"abstract":"<p>Ventricular tachycardia (VT) and VF account for the majority of sudden cardiac deaths worldwide. Treatments for VT\/VF include anti-arrhythmic drugs, ICDs and catheter ablation, but these treatments vary in effectiveness and carry substantial risks and\/or expense. Current methods of selecting patients for ICD implantation are imprecise and fail to identify some at-risk patients, while leading to others being overtreated. In this article, the authors discuss the current role and future direction of cardiac MRI (CMRI) in refining diagnosis and personalising ventricular arrhythmia management. The capability of CMRI with gadolinium contrast delayed-enhancement patterns and, more recently, T1 mapping to determine the aetiology of patients presenting with heart failure is well established. Although CMRI imaging in patients with ICDs can be challenging, recent technical developments have started to overcome this. CMRI can contribute to risk stratification, with precise and reproducible assessment of ejection fraction, quantification of scar and \u2018border zone\u2019 volumes, and other indices. Detailed tissue characterisation has begun to enable creation of personalised computer models to predict an individual patient\u2019s arrhythmia risk. When patients require VT ablation, a substrate-based approach is frequently employed as haemodynamic instability may limit electrophysiological activation mapping. Beyond accurate localisation of substrate, CMRI could be used to predict the location of re-entrant circuits within the scar to guide ablation.<\/p>","DOI":"10.15420\/aer.2019.5.1","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T09:07:08Z","timestamp":1565687228000},"page":"191-201","source":"Crossref","is-referenced-by-count":30,"title":["The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy"],"prefix":"10.15420","volume":"8","author":[{"given":"Tom","family":"Nelson","sequence":"first","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Department of Immunity, Infection and Cardiovascular Disease, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Department of Immunity, Infection and Cardiovascular Disease, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Clayton","sequence":"additional","affiliation":[{"name":"INSIGNEO Institute for In-Silico Medicine, University of Sheffield, Sheffield, UK; Department of Computer Science, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lee","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Department of Immunity, Infection and Cardiovascular Disease, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1056\/NEJMra000650","article-title":"Sudden death due to cardiac arrhythmias","volume":"345","author":"Huikuri","year":"2001","unstructured":"1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia","volume":"333","author":"Singh","year":"1995","unstructured":"2. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82.","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/01.CIR.0000134957.51747.6E","article-title":"Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)","volume":"110","author":"Bokhari","year":"2004","unstructured":"3. Bokhari F, Newman D, Greene M, et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112-6.","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","unstructured":"4. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","unstructured":"5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","unstructured":"6. Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2015;36:2793-867.","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","unstructured":"7. Bellenger NG, Davies LC, Francis JM, et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2:271-8.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref7","unstructured":"8. Josephson ME. Clinical Cardiac Electrophysiology: Techniques and Interpretations. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2008."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/01.CIR.88.3.915","article-title":"'Zigzag' course of activation","volume":"88","author":"de Bakker","year":"1993","unstructured":"9. de Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 1993;88:915-26.","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.hrthm.2011.07.027","article-title":"The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging","volume":"8","author":"Estner","year":"2011","unstructured":"10. Estner HL, Zviman MM, Herzka D, et al. The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm 2011;8:1942-9.","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.CIR.68.3.518","article-title":"Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates","volume":"68","author":"Fenoglio","year":"1983","unstructured":"11. Fenoglio JJ, Pham TD, Harken AH, et al. Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates. Circulation 1983;68:518-33.","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Pashakhanloo F, Herzka DA, Halperin H, et al. Role of 3-dimensional architecture of scar and surviving tissue in ventricular tachycardia: insights from high-resolution ex vivo porcine models. Circ Arrhythm Electrophysiol 2018;11:e006131.","DOI":"10.1161\/CIRCEP.117.006131"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/europace\/eut307","article-title":"Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias","volume":"16","author":"Nalliah","year":"2014","unstructured":"13. Nalliah CJ, Zaman S, Narayan A, et al. Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias. Europace 2014;16:1053-60.","journal-title":"Europace"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCEP.110.959213","article-title":"Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction","volume":"4","author":"Piers","year":"2011","unstructured":"14. Piers SRD, Wijnmaalen A, Borleffs C, et al. Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction. Circ Arrhythm Electrophysiol 2011;4:195-201.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/CIRCULATIONAHA.109.891242","article-title":"Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate","volume":"121","author":"Wijnmaalen","year":"2010","unstructured":"15. Wijnmaalen A, Schalij MJ, von der Th\u00fcsen JH, et al. Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate. Circulation 2010;121:1887-95.","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy","volume":"129","author":"Dinov","year":"2014","unstructured":"16. Dinov B, Fiedler L, Sch\u00f6nbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy. Circulation 2014;129:728-36.","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/eurheartj\/ehy168","article-title":"Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia","volume":"39","author":"Glashan","year":"2018","unstructured":"17. Glashan CA, Androulakis AFA, Tao Q, et al. Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia. Eur Heart J 2018;39:2867-75.","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0735-1097(98)00184-3","article-title":"Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry","volume":"32","author":"TJ","year":"1998","unstructured":"18. Wu TJ, Ong JJ, Hwang C, et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998;32:187-96.","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/CIRCULATIONAHA.105.602870","article-title":"Evidence for multiple mechanisms in human ventricular fibrillation","volume":"114","author":"Nash","year":"2006","unstructured":"19. Nash MP, Mourad A, Clayton RH, et al. Evidence for multiple mechanisms in human ventricular fibrillation. Circulation 2006;114:536-42.","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","unstructured":"20. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ehf2.12041","article-title":"Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high\u2010volume transplant centre","volume":"2","author":"Venero","year":"2015","unstructured":"21. Venero JV, Doyle M, Shah M, et al. Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high\u2010volume transplant centre. ESC Heart Fail 2015;2:150-9.","journal-title":"ESC Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jmri.20496","article-title":"Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm","volume":"23","author":"L-Y","year":"2006","unstructured":"22. Hsu L-Y, Natanzon A, Kellman P, et al. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:298-308.","journal-title":"J Magn Reson Imaging"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Khan JN, Nazir SA, Horsfield MA, et al. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths. BMC Res Notes 2015;8.","DOI":"10.1186\/s13104-015-1007-1"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.jacc.2004.09.020","article-title":"Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model","volume":"44","author":"Amado","year":"2004","unstructured":"24. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-9.","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Jablonowski R, Chaudhry U, van der Pals J, et al. Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in ischemic and nonischemic cardiomyopathy patients using late gadolinium enhancement border zone: comparison of four analysis methods. Circ Cardiovasc Imaging 2017;10.","DOI":"10.1161\/CIRCIMAGING.116.006105"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","unstructured":"26. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150-6.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1532-429X-15-56","article-title":"T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision","volume":"15","author":"Kellman","year":"2013","unstructured":"27. Kellman P, Arai AE, Xue H. T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson 2013;15:56.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","unstructured":"28. Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 2016;18:89.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.2016141802","article-title":"State of the art: clinical applications of cardiac T1 mapping","volume":"278","author":"EB","year":"2016","unstructured":"29. Schelbert EB, Messroghli DR. State of the art: clinical applications of cardiac T1 mapping. Radiology 2016;278:658-76.","journal-title":"Radiology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/cmc.s19005","article-title":"Native T1 mapping of the heart - a pictorial review","volume":"8","author":"Germain","year":"2014","unstructured":"30. Germain P, El Ghannudi S, Jeung M-Y, et al. Native T1 mapping of the heart - a pictorial review. Clin Med Insights Cardiol 2014;8:1-11.","journal-title":"Clin Med Insights Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12968-014-0069-x","article-title":"Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study","volume":"16","author":"Dabir","year":"2014","unstructured":"31. Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:69.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","article-title":"Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease","volume":"98","author":"Sado","year":"2012","unstructured":"32. Sado DM, Flett AS, Banypersad SM, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012;98:1436-41.","journal-title":"Heart"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1148\/radiol.12112721","article-title":"T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy","volume":"265","author":"Sibley","year":"2012","unstructured":"33. Sibley CT, Noureldin RA, Gai N, et al. T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 2012;265:724-32.","journal-title":"Radiology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jcmg.2013.05.005","article-title":"Advances in parametric mapping with CMR imaging","volume":"6","author":"Salerno","year":"2013","unstructured":"34. Salerno M, Kramer CM. Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging 2013;6:806-22.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Olausson E, Fr\u00f6jdh F, Maanja M, et al. Diffuse myocardial fibrosis measured by extracellular volume associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients more than focal fibrosis. J Am Coll Cardiol 2018;71(suppl 11):A1454.","DOI":"10.1016\/S0735-1097(18)31995-8"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCRESAHA.117.311494","article-title":"Myocardial edema on T2-weighted MRI","volume":"121","author":"Tada","year":"2017","unstructured":"36. Tada Y, Yang PC. Myocardial edema on T2-weighted MRI. Circ Res 2017;121:326-8.","journal-title":"Circ Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10741-017-9616-5","article-title":"T2 mapping and T2* imaging in heart failure","volume":"22","author":"Lota","year":"2017","unstructured":"37. Lota AS, Gatehouse PD, Mohiaddin RH. T2 mapping and T2* imaging in heart failure. Heart Fail Rev 2017;22:431-40.","journal-title":"Heart Fail Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000478901","article-title":"T1 and T2 mapping in cardiology: 'mapping the obscure object of desire'","volume":"138","author":"Mavrogeni","year":"2017","unstructured":"38. Mavrogeni S, Apostolou D, Argyriou P, et al. T1 and T2 mapping in cardiology: 'mapping the obscure object of desire'. Cardiology 2017;138:207-17.","journal-title":"Cardiology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","unstructured":"39. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016;37:2129-200.","journal-title":"Eur Heart J"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2018;72:e91-220.","DOI":"10.1016\/j.jacc.2017.10.054"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/CIRCIMAGING.111.966085","article-title":"Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias","volume":"5","author":"White","year":"2012","unstructured":"41. White JA, Fine NM, Gula L, et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging 2012;5:12-20.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCEP.113.000537","article-title":"Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy","volume":"6","author":"Piers","year":"2013","unstructured":"42. Piers SRD, Tao Q, van Huls van Taxis CF, et al. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol 2013;6:875-83.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0735-1097(86)80325-4","article-title":"Reversible ischemic left ventricular dysfunction: Evidence for the 'hibernating myocardium","volume":"8","author":"Braunwald","year":"1986","unstructured":"43. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the 'hibernating myocardium. J Am Coll Cardiol 1986;8:1467-70.","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0735-1097(00)01133-5","article-title":"Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome","volume":"37","author":"Brugada","year":"2001","unstructured":"44. Brugada J, Aguinaga L, Mont L, et al. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol 2001;37:529-33.","journal-title":"J Am Coll Cardiol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.athoracsur.2007.12.035","article-title":"Early and late survival after surgical revascularization for ischemic ventricular fibrillation\/tachycardia","volume":"85","author":"Ngaage","year":"2008","unstructured":"45. Ngaage DL, Cale ARJ, Cowen ME, et al. Early and late survival after surgical revascularization for ischemic ventricular fibrillation\/tachycardia. Ann Thorac Surg 2008;85:1278-81.","journal-title":"Ann Thorac Surg"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0735-1097(10)80046-4","article-title":"Surgical coronary revascularization in survivors of prehospital cardiac arrest: Its effect on inducible ventricular arrhythmias and long-term survival","volume":"15","author":"Kelly","year":"1990","unstructured":"46. Kelly P, Ruskin JN, Vlahakes GJ, et al. Surgical coronary revascularization in survivors of prehospital cardiac arrest: Its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990;15:267-73.","journal-title":"J Am Coll Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1540-8159.1999.tb00591.x","article-title":"Coronary artery bypass grafting and defibrillator implantation in patients with ventricular tachyarrhythmias and ischemic heart disease","volume":"22","author":"Geelen","year":"1999","unstructured":"47. Geelen P, Primo J, Wellens F, Brugada P. Coronary artery bypass grafting and defibrillator implantation in patients with ventricular tachyarrhythmias and ischemic heart disease. Pacing Clin Electrophysioly 1999;22:1132-9.","journal-title":"Pacing Clin Electrophysioly"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jcin.2016.02.001","article-title":"Emergency percutaneous coronary intervention in post-cardiac arrest patients without st-segment elevation pattern: insights from the PROCAT II Registry","volume":"9","author":"Dumas","year":"2016","unstructured":"48. Dumas F, Bougouin W, Geri G, et al. Emergency percutaneous coronary intervention in post-cardiac arrest patients without st-segment elevation pattern: insights from the PROCAT II Registry. JACC Cardiovasc Interv 2016;9:1011-8.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1067\/mhj.2002.121732","article-title":"Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry","volume":"143","author":"Cook","year":"2002","unstructured":"49. Cook JR, Rizo-Patron C, Curtis AB, et al. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Am Heart J 2002;143:821-6.","journal-title":"Am Heart J"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jcmg.2008.09.010","article-title":"Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study","volume":"2","author":"Kwon","year":"2009","unstructured":"50. Kwon DH, Halley CM, Carrigan TP, et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009;2:34-44.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1161\/CIRCIMAGING.111.964965","article-title":"Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study","volume":"4","author":"Klem","year":"2011","unstructured":"51. Klem I, Shah DJ, White RD, et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging 2011;4:610-9.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.109.852517","article-title":"Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction","volume":"120","author":"Cheong","year":"2009","unstructured":"52. Cheong BYC, Muthupillai R, Wilson JM, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009;120:2069-76.","journal-title":"Circulation"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCEP.110.959544","article-title":"The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators","volume":"4","author":"Scott","year":"2011","unstructured":"53. Scott PA, Morgan JM, Carroll N, et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011;4:324-30.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jacc.2004.12.057","article-title":"Infarct morphology identifies patients with substrate for sustained ventricular tachycardia","volume":"45","author":"Bello","year":"2005","unstructured":"54. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","unstructured":"55. Disertori M, Rigoni M, Pace N, et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging 2016;9:1046-55.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCIMAGING.111.971549","article-title":"Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging","volume":"5","author":"Gao","year":"2012","unstructured":"56. Gao P, Yee R, Gula L, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012;5:448-56.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1016\/j.jacc.2010.01.052","article-title":"Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events","volume":"55","author":"Heidary","year":"2010","unstructured":"57. Heidary S, Patel H, Chung J, et al. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. J Am Coll Cardiol 2010;55:2762-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCULATIONAHA.106.613414","article-title":"Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality","volume":"114","author":"Yan","year":"2006","unstructured":"58. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9.","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5603\/CJ.2013.0011","article-title":"A comparison of cardiac magnetic resonance imaging peri-infarct border zone quantification strategies for the prediction of ventricular tachyarrhythmia inducibility","volume":"20","author":"Rubenstein","year":"2013","unstructured":"59. Rubenstein JC, Lee DC, Wu E, et al. A comparison of cardiac magnetic resonance imaging peri-infarct border zone quantification strategies for the prediction of ventricular tachyarrhythmia inducibility. Cardiol J 2013;20:68-77.","journal-title":"Cardiol J"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy","volume":"11","author":"Acosta","year":"2018","unstructured":"60. Acosta J, Fern\u00e1ndez-Armenta J, Borr\u00e0s R, et al. Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy. JACC Cardiovasc Imaging 2018;11:561-72.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"KC","year":"2008","unstructured":"61. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:2414-21.","journal-title":"J Am Coll Cardiol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","unstructured":"62. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.","journal-title":"J Am Coll Cardiol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","unstructured":"63. Halliday BP, Gulati A, Ali A, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation 2017;135:2106-15.","journal-title":"Circulation"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis","volume":"11","author":"Becker","year":"2018","unstructured":"64. Becker MAJ, Cornel JH, van de Ven PM, et al. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC Cardiovasc Imaging 2018;11:1274-84.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"65. Halliday BP, Baksi AJ, Gulati A, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc Imaging 2018.","DOI":"10.1016\/j.jcmg.2018.07.015"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on CMR predicts adverse cardiovascular outcomes in non-ischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","unstructured":"66. Kuruvilla S, Adenaw N, Katwal AB, et al. Late gadolinium enhancement on CMR predicts adverse cardiovascular outcomes in non-ischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 2014;7:250-8.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.amjcard.2005.03.051","article-title":"Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators","volume":"96","author":"Ermis","year":"2005","unstructured":"67. Ermis C, Zhu AX, Vanheel L, et al. Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators. Am J Cardiol 2005;96:233-8.","journal-title":"Am J Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.hrthm.2015.05.026","article-title":"Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy","volume":"12","author":"Piers","year":"2015","unstructured":"68. Piers SRD, Everaerts K, van der Geest RJ, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm 2015;12:2106-14.","journal-title":"Heart Rhythm"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","unstructured":"69. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017;19:75.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.hrthm.2014.12.020","article-title":"Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators","volume":"12","author":"Chen","year":"2015","unstructured":"70. Chen Z, Sohal M, Voigt T, et al. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators. Heart Rhythm 2015;12:792-801.","journal-title":"Heart Rhythm"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","article-title":"Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality","volume":"126","author":"Wong","year":"2012","unstructured":"71. Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126:1206-16.","journal-title":"Circulation"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"72. Barison A, Torto AD, Chiappino S, et al. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med 2015;16.","DOI":"10.2459\/JCM.0000000000000275"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"K-H","year":"2010","unstructured":"73. Kuck K-H, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.","journal-title":"Lancet"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","unstructured":"74. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016;375:111-21.","journal-title":"N Engl J Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT Trial","volume":"67","author":"Marchlinski","year":"2016","unstructured":"75. Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT Trial. J Am Coll Cardiol 2016;67:674-83.","journal-title":"J Am Coll Cardiol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","unstructured":"76. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/01.CIR.101.11.1288","article-title":"Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy","volume":"101","author":"Marchlinski","year":"2000","unstructured":"77. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288-96.","journal-title":"Circulation"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCEP.114.002310","article-title":"Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias","volume":"8","author":"Tzou","year":"2015","unstructured":"78. Tzou WS, Frankel DS, Hegeman T, et al. Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythm Electrophysiol 2015;8:353-61.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2016.08.033","article-title":"Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia","volume":"68","author":"G\u00f6kog\u02d8 lan","year":"2016","unstructured":"79. G\u00f6kog\u02d8 lan Y, Mohanty S, Gianni C, et al. Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol 2016;68:1990-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.111.043216","article-title":"Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia","volume":"125","author":"Ja\u00efs","year":"2012","unstructured":"80. Ja\u00efs P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012;125:2184-96.","journal-title":"Circulation"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCEP.111.961946","article-title":"Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation","volume":"4","author":"Andreu","year":"2011","unstructured":"81. Andreu D, Berruezo A, Ortiz-P\u00e9rez JT, et al. Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2011;4:674-83.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"11437","DOI":"10.1038\/ncomms11437","article-title":"Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models","volume":"7","author":"Arevalo","year":"2016","unstructured":"82. Arevalo HJ, Vadakkumpadan F, Guallar E, et al. Arrhythmia risk stratification of patients after myocardial infarction using personalized heart models. Nat Commun 2016;7:11437.","journal-title":"Nat Commun"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jacc.2009.05.032","article-title":"Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy","volume":"54","author":"Cano","year":"2009","unstructured":"83. Cano O, Hutchinson M, Lin D, et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol 2009;54:799-808.","journal-title":"J Am Coll Cardiol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCEP.114.001568","article-title":"Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types","volume":"7","author":"Oloriz","year":"2014","unstructured":"84. Oloriz T, Silberbauer J, Maccabelli G, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol 2014;7:414-23.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.hrthm.2017.05.018","article-title":"Cardiac magnetic resonance-aided scar dechanneling: Influence on acute and long-term outcomes","volume":"14","author":"Andreu","year":"2017","unstructured":"85. Andreu D, Penela D, Acosta J, et al. Cardiac magnetic resonance-aided scar dechanneling: Influence on acute and long-term outcomes. Heart Rhythm 2017;14:1121-8.","journal-title":"Heart Rhythm"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jcmg.2016.03.009","article-title":"Multimodality imaging for guiding EP ablation procedures","volume":"9","author":"Njeim","year":"2016","unstructured":"86. Njeim M, Desjardins B, Bogun F. Multimodality imaging for guiding EP ablation procedures. JACC Cardiovasc Imaging 2016;9:873-86.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jce.12963","article-title":"Image integration to guide catheter ablation in scar-related ventricular tachycardia","volume":"27","author":"Yamashita","year":"2016","unstructured":"87. Yamashita S, Sacher F, Mahida S, et al. Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol 2016;27:699-708.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"88. Kelland NF, Metherall P, Sugden J, et al. Multimodality image reconstruction and fusion to guide VT ablation. Europace 2017;19 (suppl 1):i17.","DOI":"10.1093\/europace\/eux283.047"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/eurheartj\/ehq345","article-title":"Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration","volume":"32","author":"Wijnmaalen","year":"2011","unstructured":"89. Wijnmaalen AP, van der Geest RJ, van Huls van Taxis CFB, et al. Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. Eur Heart J 2011;32:104-14.","journal-title":"Eur Heart J"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacep.2017.02.024","article-title":"Real-time localization of ventricular tachycardia origin from the 12-lead electrocardiogram","volume":"3","author":"Sapp","year":"2017","unstructured":"90. Sapp JL, Bar-Tal M, Howes AJ, et al. Real-time localization of ventricular tachycardia origin from the 12-lead electrocardiogram. JACC Clin Electrophysiol 2017;3:687-99.","journal-title":"JACC Clin Electrophysiol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.hrthm.2018.06.013","article-title":"A QRS axis-based algorithm to identify the origin of scar-related ventricular tachycardia in the 17-segment American Heart Association model","volume":"15","author":"Andreu","year":"2018","unstructured":"91. Andreu D, Fern\u00e1ndez-Armenta J, Acosta J, et al. A QRS axis-based algorithm to identify the origin of scar-related ventricular tachycardia in the 17-segment American Heart Association model. Heart Rhythm 2018;15:1491-7.","journal-title":"Heart Rhythm"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1540-8167.2007.00721.x","article-title":"A novel algorithm for determining endocardial VT exit site from 12-lead surface ECG characteristics in human, infarct-related ventricular tachycardia","volume":"18","author":"Segal","year":"2007","unstructured":"92. Segal OR, Chow AWC, Wong T, et al. A novel algorithm for determining endocardial VT exit site from 12-lead surface ECG characteristics in human, infarct-related ventricular tachycardia. J Cardiovasc Electrophysiol 2007;18:161-8.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/01.CIR.77.4.759","article-title":"Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease","volume":"77","author":"Miller","year":"1988","unstructured":"93. Miller JM, Marchlinski FE, Buxton AE, Josephson ME. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. Circulation 1988;77:759-66.","journal-title":"Circulation"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0735-1097(89)90232-5","article-title":"Electrocardiographic localization of the site of origin of ventricular tachycardia in patients with prior myocardial infarction","volume":"13","author":"Kuchar","year":"1989","unstructured":"94. Kuchar DL, Ruskin JN, Garan H. Electrocardiographic localization of the site of origin of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 1989;13:893-903.","journal-title":"J Am Coll Cardiol"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"95. Wang Y, Cuculich PS, Zhang J, et al. Noninvasive electroanatomic mapping of human ventricular arrhythmias with electrocardiographic imaging. Sci Transl Med 2011;3:98ra84.","DOI":"10.1126\/scitranslmed.3002152"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1540-8159.2005.50024.x","article-title":"Current clinical issues for MRI scanning of pacemaker and defibrillator patients","volume":"28","author":"Kalin","year":"2005","unstructured":"96. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005;28:326-8.","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"415","DOI":"10.7326\/0003-4819-155-7-201110040-00004","article-title":"A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices","volume":"155","author":"Nazarian","year":"2011","unstructured":"97. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011;155:415-24.","journal-title":"Ann Intern Med"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1056\/NEJMoa1603265","article-title":"Assessing the risks associated with MRI in patients with a pacemaker or defibrillator","volume":"376","author":"Russo","year":"2017","unstructured":"98. Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med 2017;376:755-64.","journal-title":"N Engl J Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.hrthm.2017.10.003","article-title":"Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices","volume":"15","author":"DH","year":"2018","unstructured":"99. Do DH, Eyvazian V, Bayoneta AJ, et al. Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices. Heart Rhythm 2018;15:218-25.","journal-title":"Heart Rhythm"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCIMAGING.108.835793","article-title":"Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart","volume":"3","author":"Schelbert","year":"2010","unstructured":"100. Schelbert EB, Hsu L-Y, Anderson SA, et al. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging 2010;3:743-52.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2463\/mrms.rev.2016-0116","article-title":"Three-dimensional cardiac MR imaging: related techniques and clinical applications","volume":"16","author":"Amano","year":"2017","unstructured":"101. Amano Y, Yanagisawa F, Tachi M, et al. Three-dimensional cardiac MR imaging: related techniques and clinical applications. Magn Reson Med Sci 2017;16:183-9.","journal-title":"Magn Reson Med Sci"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jmri.24759","article-title":"Super-resolution reconstruction of late gadolinium-enhanced MRI for improved myocardial scar assessment","volume":"42","author":"Dzyubachyk","year":"2015","unstructured":"102. Dzyubachyk O, Tao Q, Poot DHJ, et al. Super-resolution reconstruction of late gadolinium-enhanced MRI for improved myocardial scar assessment. J Magn Reson Imaging 2015;42:160-7.","journal-title":"J Magn Reson Imaging"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/joa.12395","article-title":"Inhomogeneity of collagen organization within the fibrotic scar after myocardial infarction: results in a swine model and in human samples","volume":"228","author":"Hervas","year":"2016","unstructured":"103. Hervas A, Ruiz\u2010Sauri A, de Dios E, et al. Inhomogeneity of collagen organization within the fibrotic scar after myocardial infarction: results in a swine model and in human samples. J Anat 2016;228:47-58.","journal-title":"J Anat"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"104. Le\u00f3n DG, L\u00f3pez-Yunta M, Alfonso-Almaz\u00e1n JM, et al. Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction. Europace 2019.","DOI":"10.1093\/europace\/euy306"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/nbm.3426","article-title":"Diffusion MRI in the heart","volume":"30","author":"Mekkaoui","year":"2017","unstructured":"105. Mekkaoui C, Reese TG, Jackowski MP, et al. Diffusion MRI in the heart. NMR Biomed 2017;30:3.","journal-title":"NMR Biomed"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"106. Disertori M, Mas\u00e8 M, Rigoni M, et al. Ventricular tachycardia-inducibility predicts arrhythmic events in post-myocardial infarction patients with low ejection fraction. A systematic review and meta-analysis. Int J Cardiol Heart Vasc 2018;20:7-13.","DOI":"10.1016\/j.ijcha.2018.06.002"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"107. Plummer C. Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation? Europace 2009;11:273-5.","DOI":"10.1093\/europace\/eun392"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.hrthm.2009.09.025","article-title":"Mechanisms that initiate ventricular tachycardia in the infarcted human heart","volume":"7","author":"Segal","year":"2010","unstructured":"108. Segal OR, Chow AWC, Peters NS, et al. Mechanisms that initiate ventricular tachycardia in the infarcted human heart. Heart Rhythm 2010;7:57-64.","journal-title":"Heart Rhythm"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"109. Deng D, Arevalo HJ, Prakosa A, et al. A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction. Europace 2016;18:iv60-6.","DOI":"10.1093\/europace\/euw351"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41551-018-0282-2","article-title":"Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia","volume":"2","author":"Prakosa","year":"2018","unstructured":"110. Prakosa A, Arevalo HJ, Deng D, et al. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nat Biomed Eng 2018;2:732-40.","journal-title":"Nat Biomed Eng"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1113\/JP271671","article-title":"Uncertainty and variability in computational and mathematical models of cardiac physiology","volume":"594","author":"Mirams","year":"2016","unstructured":"111. Mirams GR, Pathmanathan P, Gray RA, et al. Uncertainty and variability in computational and mathematical models of cardiac physiology. J Physiol 2016;594:6833-47.","journal-title":"J Physiol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","unstructured":"112. K\u00f8ber L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221-30.","journal-title":"N Engl J Med"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"113. Selvanayagam JB, Hartshorne T, Billot L, et al. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol 2017;22.","DOI":"10.1111\/anec.12420"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.hlc.2016.04.007","article-title":"Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): trial protocol, background and significance","volume":"25","author":"Zaman","year":"2016","unstructured":"114. Zaman S, Taylor AJ, Stiles M, et al. Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): trial protocol, background and significance. Heart Lung Circ 2016;25:1055-62.","journal-title":"Heart Lung Circ"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"85","DOI":"10.15420\/aer.2017:1:2","article-title":"Cardiac electrophysiology under MRI guidance: an emerging technology","volume":"6","author":"Chubb","year":"2017","unstructured":"115. Chubb H, Williams SE, Whitaker J, et al. Cardiac electrophysiology under MRI guidance: an emerging technology. Arrhythm Electrophysiol Rev 2017;6:85-93.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/europace\/euv249","article-title":"Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series","volume":"18","author":"Hilbert","year":"2016","unstructured":"116. Hilbert S, Sommer P, Gutberlet M, et al. Real-time magnetic resonance-guided ablation of typical right atrial flutter using a combination of active catheter tracking and passive catheter visualization in man: initial results from a consecutive patient series. Europace 2016;18:572-7.","journal-title":"Europace"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","article-title":"Noninvasive cardiac radiation for ablation of ventricular tachycardia","volume":"377","author":"Cuculich","year":"2017","unstructured":"117. Cuculich PS, Schill MR, Kashani R, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med 2017;377:2325-36.","journal-title":"N Engl J Med"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","article-title":"Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia","volume":"139","author":"Robinson","year":"2019","unstructured":"118. Robinson CG, Samson PP, Moore KM, et al. Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation 2019;139:313-321.","journal-title":"Circulation"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","article-title":"Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction","volume":"115","author":"Schmidt","year":"2007","unstructured":"119. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14.","journal-title":"Circulation"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/CIRCIMAGING.108.826529","article-title":"Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator","volume":"2","author":"Roes","year":"2009","unstructured":"120. Roes SD, Borleffs CJW, van der Geest RJ, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009;2:183-90.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.jacc.2009.07.027","article-title":"Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging","volume":"54","author":"Kelle","year":"2009","unstructured":"121. Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009;54:1770-7.","journal-title":"J Am Coll Cardiol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1532-429X-13-2","article-title":"Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion","volume":"13","author":"Krittayaphong","year":"2011","unstructured":"122. Krittayaphong R, Saiviroonporn P, Boonyasirinant T, et al. Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion. J Cardiovasc Magn Reson 2011;13:2.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jcmg.2011.04.014","article-title":"Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR","volume":"4","author":"Boy\u00e9","year":"2011","unstructured":"123. Boy\u00e9 P, Abdel-Aty H, Zacharzowsky U, et al. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging 2011;4:871-9.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1532-429X-15-12","article-title":"Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease","volume":"15","author":"Alexandre","year":"2013","unstructured":"124. Alexandre J, Saloux E, Dugu\u00e9 AE, et al. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson 2013;15:12.","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/heartjnl-2013-304261","article-title":"Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender","volume":"100","author":"Kwon","year":"2014","unstructured":"125. Kwon DH, Hachamovitch R, Adeniyi A, et al. Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender. Heart 2014;100:206-13.","journal-title":"Heart"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ijcard.2014.08.132","article-title":"Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy","volume":"177","author":"Demirel","year":"2014","unstructured":"126. Demirel F, Adiyaman A, Timmer JR, et al. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy. Int J Cardiol 2014;177:392-9.","journal-title":"Int J Cardiol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/heartjnl-2015-308467","article-title":"Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction","volume":"102","author":"Rijnierse","year":"2016","unstructured":"127. Rijnierse MT, Allaart CP, Haan S de, et al. Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction. Heart 2016;102:832-40.","journal-title":"Heart"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","unstructured":"128. Iles L, Pfluger H, Lefkovits L, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 2011;57:821-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/hrt.2010.205542","article-title":"Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy","volume":"97","author":"Lehrke","year":"2011","unstructured":"129. Lehrke S, Lossnitzer D, Sch\u00f6b M, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011;97:727-32.","journal-title":"Heart"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jcmg.2013.05.013","article-title":"CMR Quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy","volume":"6","author":"Neilan","year":"2013","unstructured":"130. Neilan TG, Coelho-Filho OR, Danik SB, et al. CMR Quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 2013;6:944-54.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","unstructured":"131. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309:896-908.","journal-title":"JAMA"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mri.2013.10.011","article-title":"Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome","volume":"32","author":"Machii","year":"2014","unstructured":"132. Machii M, Satoh H, Shiraki K, et al. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome. Magn Reson Imaging 2014;32:118-24.","journal-title":"Magn Reson Imaging"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","article-title":"Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy","volume":"11","author":"Perazzolo Marra","year":"2014","unstructured":"133. Perazzolo Marra M, De Lazzari M, Zorzi A, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm 2014;11:856-63.","journal-title":"Heart Rhythm"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","article-title":"Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure","volume":"7","author":"Masci","year":"2014","unstructured":"134. Masci PG, Doulaptsis C, Bertella E, et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 2014;7:448-56.","journal-title":"Circ Heart Fail"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2016.07.122","article-title":"Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy","volume":"222","author":"Shin","year":"2016","unstructured":"135. Shin DG, Lee H-J, Park J, et al. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy. Int J Cardiol 2016;222:9-15.","journal-title":"Int J Cardiol"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"136. Mueller KAL, Heck C, Heinzmann D, et al. Comparison of ventricular inducibility with late gadolinium enhancement and myocardial inflammation in endomyocardial biopsy in patients with dilated cardiomyopathy. PLoS One 2016;11:e0167616.","DOI":"10.1371\/journal.pone.0167616"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","unstructured":"137. Puntmann VO, Carr-White G, Jabbour A, et al. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure. JACC Cardiovasc Imaging 2016;9:40-50.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","article-title":"Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease","volume":"113","author":"Kwong","year":"2006","unstructured":"138. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43.","journal-title":"Circulation"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jcmg.2012.09.012","article-title":"Prognostic role of CMR in patients presenting with ventricular arrhythmias","volume":"6","author":"Dawson","year":"2013","unstructured":"139. Dawson DK, Hawlisch K, Prescott G, et al. Prognostic role of CMR in patients presenting with ventricular arrhythmias. JACC Cardiovasc Imaging 2013;6:335-44.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCIMAGING.113.001768","article-title":"Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy","volume":"7","author":"Almehmadi","year":"2014","unstructured":"140. Almehmadi F, Joncas SX, Nevis I, et al. Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Circ Cardiovasc Imaging 2014;7:593-600.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jcmg.2015.02.005","article-title":"The combined incremental prognostic value of LVEF, late gadolinium enhancement, and global circumferential strain assessed by CMR","volume":"8","author":"Mordi","year":"2015","unstructured":"141. Mordi I, Bezerra H, Carrick D, Tzemos N. The combined incremental prognostic value of LVEF, late gadolinium enhancement, and global circumferential strain assessed by CMR. JACC Cardiovasc Imaging 2015;8:540-9.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articles\/Cardiac-MRI-Ventricular-Arrhythmias-Ischaemic-Non-Ischaemic-Dilated-Cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:46:00Z","timestamp":1783615560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2019.5.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":141,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,8,9]]},"published-print":{"date-parts":[[2019,8,9]]}},"alternative-id":["aer.2019.5.1"],"URL":"https:\/\/doi.org\/10.15420\/aer.2019.5.1","relation":{},"ISSN":["2050-3369","2050-3377"],"issn-type":[{"value":"2050-3369","type":"print"},{"value":"2050-3377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]}}}